Clinical Trial Update: Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of REN-1654 for post-herpetic neuralgia, sponsored by Renovis, is described as an update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Postherpetic Neuralgia

Drugs mentioned

• REN-1654

Snippet

Sponsor: Renovis | Conditions: Neuralgia, Shingles | Phase 2 | Status: UNKNOWN